Studies have indicated that aberrant KPNA2 expression can be found in early lesions, such as ductal carcinoma in situ (DSIS) in breast cancer [20] and non-invasive bladder cancer samples [21]. This evidence concerns the gene KPNA2 and urinary bladder cancer.